Yun Shin Chun
The University of Texas MD Anderson Cancer Center
Appearances
DateMay 9, 2023Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center- DateMay 9, 2023Long-term survival in patients with localized pancreatic adenocarcinoma (PDAC) or ampullary adenocarcinoma (AA) who undergo resection is rare, even in lymph node (LN)-negative disease…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center - DateMay 9, 2023Background: Sarcomas are rare mesenchymal tumors with a propensity for hematogenous metastasis, leading to liver metastasis. Advancements in liver surgery have led to increased resection of sarcomatous liver metastasis as discussed in several studies…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center 
DateMay 7, 2023Sentinel node navigated surgery (SNNS) might offer a less invasive alternative to esophagectomy to tailor the extent of lymphadenectomy in patients with high-risk T1 esophageal adenocarcinoma (EAC)…Presenter
Speakers
The University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center- DateMay 8, 2023Pancreatic Adenocarcinoma (PDAC) is highly lethal due to overwhelming metastatic burden. The mechanisms underpinning metastasis in PDAC are lacking. The TMEM doorway is the sole portal of intravasation in breast cancer (BC)…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center - DateMay 8, 2023Pancreatic Adenocarcinoma (PDAC) is highly lethal due to overwhelming metastatic burden. The mechanisms underpinning metastasis in PDAC are lacking. The TMEM doorway is the sole portal of intravasation in breast cancer (BC)…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center 
DateMay 8, 2023SOCIETY: SSATModerators
The University of Texas MD Anderson Cancer CenterMedstar Georgetown University HospitalThe University of TokyoAmerican British Cowdray Medical Center- DateMay 6, 2023LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center - DateMay 6, 2023LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center - DateMay 6, 2023LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center - DateMay 20, 2024INTRODUCTION: Carcinoembryonic antigen (CEA) levels may change after preoperative chemotherapy discontinuation before surgery for colorectal liver metastases (CLM)…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center - DateMay 19, 2024Prognosis after hepatectomy for multifocal intrahepatic cholangiocarcinoma (iCCA) is worse than for unifocal iCCA with reported post-operative survival of under 2 years. As a result, multifocality must be carefully considered prior to resection…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center - DateMay 19, 2024INTRODUCTION: Variations in hepatic arterial and portal venous anatomy have previously been described; however, a comprehensive evaluation of hepatic vascular anatomy that includes other critical elements relevant to hepatectomy is lacking…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center - DateMay 19, 2024Introduction: Though still common practice, the indications for surgical drain placement following hepatectomy have been put into question…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center - DateMay 21, 2024INTRODUCTION: Pathologic response after preoperative chemotherapy has been associated with overall survival, and RAS mutational status could stratify patients with minor pathologic response (>50%)…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterMD Anderson Cancer Center - DateMay 21, 2024Background: Surgeons may consider parenchymal-sparing (PSH) or one-stage major hepatectomy (MH) for patients with bilateral colorectal liver metastases (CLM). However, outcomes of these two approaches for patients with advanced bilateral disease are underreported…
Presenter
Speakers
The University of Texas MD Anderson Cancer CenterMD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
